Skip to main content
NERV
NASDAQ Life Sciences

Federated Hermes Kaufmann Fund Files Intent to Sell $3.39M in Minerva Neurosciences Stock

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
7
Price
$7.86
Mkt Cap
$343.599M
52W Low
$1.15
52W High
$12.46
Market data snapshot near publication time

summarizeSummary

Federated Hermes Kaufmann Fund, a 10% stockholder, filed a Form 144 indicating its intent to sell 424,278 shares of Minerva Neurosciences common stock, valued at approximately $3.39 million.


check_boxKey Events

  • Intent to Sell Shares

    Federated Hermes Kaufmann Fund, a 10% stockholder, filed a Form 144 to sell 424,278 shares of common stock.

  • Significant Transaction Value

    The proposed sale has an approximate market value of $3.39 million.

  • Institutional Investor Activity

    This filing indicates a potential reduction in holdings by a major institutional investor, following a similar filing from a related fund today.


auto_awesomeAnalysis

This Form 144 signals a significant potential reduction in stake by a major institutional investor. While the sale is for liquidity or portfolio rebalancing purposes typical of a 10% owner, the proposed value of $3.39 million represents a notable transaction for Minerva Neurosciences. Investors should monitor for actual sales, as a large block sale could create near-term selling pressure. This follows another Form 144 filing from a related Federated Hermes fund earlier today.

At the time of this filing, NERV was trading at $7.86 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $343.6M. The 52-week trading range was $1.15 to $12.46. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed NERV - Latest Insights

NERV
Apr 23, 2026, 7:02 AM EDT
Filing Type: DEFA14A
Importance Score:
7
NERV
Apr 23, 2026, 7:00 AM EDT
Filing Type: DEF 14A
Importance Score:
7
NERV
Apr 10, 2026, 9:20 AM EDT
Filing Type: PRE 14A
Importance Score:
7
NERV
Apr 02, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
NERV
Mar 11, 2026, 9:20 AM EDT
Filing Type: S-3
Importance Score:
8
NERV
Mar 11, 2026, 8:00 AM EDT
Filing Type: 10-K
Importance Score:
9
NERV
Mar 11, 2026, 7:07 AM EDT
Filing Type: 8-K
Importance Score:
8
NERV
Mar 11, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
NERV
Mar 10, 2026, 5:15 PM EDT
Filing Type: 144
Importance Score:
7
NERV
Mar 10, 2026, 5:15 PM EDT
Filing Type: 144
Importance Score:
7